Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Euronext Bruxelles  >  UCB    UCB

UCB (UCB)

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Bruxelles
07/27/2015 07/28/2015 07/29/2015 07/30/2015 07/31/2015 Date
69.5(c) 67(c) 66.84(c) 67(c) 70.46(c) Last
215 260 979 719 405 255 444 651 956 560 Volume
-1.52% -3.60% -0.24% +0.24% +5.16% Change
More quotes
Financials (€)
Sales 2015 3 631 M
EBIT 2015 520 M
Net income 2015 282 M
Debt 2015 1 507 M
Yield 2015 1,61%
Sales 2016 3 892 M
EBIT 2016 645 M
Net income 2016 386 M
Debt 2016 1 354 M
Yield 2016 1,73%
PER 2015 37,83
PER 2016 32,45
EV / Sales 2015 4,19x
EV / Sales 2016 3,87x
Capitalization 13 705 M
More Financials
Company
UCB SA is a biopharmaceutical company that engages in the research, development and commercialization of innovative drugs in the fields of central nervous system and immunology disorders.It focuses on the discovery and development of innovative medicines and solutions to transform the lives of... 
Sector
Pharmaceuticals
Calendar
07/31 | 01:00amEarnings Release
More about the company
Surperformance© ratings of UCB
Trading Rating : Investor Rating :
More Ratings
Latest news on UCB
07/06 UCB : DEA Issues Notice on Importer of Controlled Substances Application from Kr..
07/06 UCB : Importer of Controlled Substances Application: Kremers Urban Pharmaceutica..
06/24 CIPLA : Lupin readies Rs7,500 cr chest for buyouts
06/01 Lupin, cipla bid for ucb's $1 billion generics unit
06/01 CIPLA : LUPIN, CIPLA BID FOR UCB's $1 BILLION US GENERICS UNIT
05/27 UCB : Patent Issued for Pharmaceutical Composition Comprising Rotigotine Salts (..
05/04 UCB : ex-dividend day for annual dividend
04/02 DR REDDY LABORATORIES : Labs to Acquire Brands Portfolio of UCB for USD128 Milli..
More news
Sector news : Biopharmaceuticals
07/31 HOSPIRA : Citing vulnerability to hacking, FDA says hospitals should stop using ..
07/31 HOSPIRA : Citing hacking risk, FDA says Hospira pump shouldn't be used
07/31DJWHO Says Ebola Vaccine Effective in African Trial -- Update
More sector news : Biopharmaceuticals
News from SeekingAlpha
12:25p UCB's (UCBJF) CEO Jean-Christophe Tellier on Q2 2015 Results - Earnings Call ..
06/21 WEEK IN REVIEW : Livzon Leads $26 Million Funding Of Cynvenio
02/08 WEEK IN REVIEW : WuXi NextCode Leads $15 Million Financing In Claritas Genomics


Comments 
Advertisement
Chart UCB
Duration : Period :
UCB Technical Analysis Chart | UCB | BE0003739530 | 4-Traders
Full-screen chart
Technical analysis trends UCB
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions